Further to DrugAlert Volume 535, HPS Pharmacies wish to give notice that Pfizer Australia has announced the discontinuation of Isuprel™ ampoules as follows:
Isuprel™ 1:5000 Ampoules
Stock of Isuprel™ 1:5000 200mcg/1mL is expected to be depleted by end June 2020. Pfizer advises that alternative therapeutic options should be guided by clinical experts within each facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer Australia on 1800 675 229 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates